Generic drug of the therapeutic class: Dermatology
Active ingredients: [Other Ã~mollients and protectors, 4491]
laboratory: Pierre Fabre Medicament
500 g pump bottle
All forms
Indication
Treatment of cutaneous dryness associated with certain dermatoses such as atopic dermatitis and ichthyosis. A medical opinion is necessary to make the initial diagnosis of these dermatoses.
Dosage DEXERYLCARE cream bottle 500 g pump
Treatment of cutaneous dryness associated with certain dermatoses such as atopic dermatitis and ichthyosis. A medical opinion is necessary to make the initial diagnosis of these dermatoses.
Against indications
Hypersensitivity to the active substances or to any of the excipients listed under Composition .
Dexerylcare side effects
The following undesirable effects have been reported in clinical studies and since the marketing of this medicinal product:
Very often (≥1 / 10)
Frequent (≥1 / 100 to "<1/10)
Not very frequent (≥1 / 1, 000 to <1/100)
Rare (≥1 / 10, 000 to "<1/1000)
Very rare (<1 / 10, 000)
Frequency unknown (can not be estimated based on available data).
Class of organ systems | Frequencies of undesirable effects | |
Not very frequent | Unknown frequency | |
Skin and subcutaneous tissue disorders | Urticaria, contact dermatitis, eczÚma, ÚrythÞme, pruritus, rash | burning sensation of the skin, tingling sensation of the skin |
General disorders and administration site abnormalities | irritation, redness, pain, itching | eczÚma at the application site |
Declaration of suspected undesirable effects
The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Healthcare professionals declare any suspected adverse effects via the national system of declaration: National Agency for the Safety of Medicines and Health Products (ANSM) and the Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.
